Skip to main content
Premium Trial:

Request an Annual Quote

Ben Bulkley, Bernd Brust, John Radak, Kelli Richard

Premium
Ben Bulkley and Invitrogen have mutually agreed for his departure from the company, Invitrogen said in a document filed with the US Securities and Exchange Commission this week. Bulkley is senior vice president of commercial operations. His departure date is Jan. 31. Bernd Brust, senior vice president of global sales, will replace him.
 
The company also announced the resignation of John Radak as VP for finance and principal accounting officer, effective Jan. 31. He will be replaced by Kelli Richard, who has been corporate controller at Invitrogen since August 2005. Richard will receive a base salary of $225,000 in her new position.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.